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There is little information on the diversity of non-tuberculous mycobacteria (NTM) in 
New Zealand. This project has shown that diverse mycobacteria can be isolated from 
forest, pastoral and urban environments through the combined use of specialised 
decontamination techniques and selective media. Mycobacterium avium-
intracellulare complex (MAIC) was the most commonly isolated mycobacteria (40%) 
followed by M montefiorense/M triplex (20%). This is the first known isolation of M 
montefiorense/M triplex from soils in New Zealand. The greatest numbers of 
mycobacteria were isolated from peat-rich pastoral soils, followed by urban 
dust/organic matter and native forest soils. The majority of mycobacteria isolated 
were slow-growing. The greatest numbers of iso lates that were unable to be speciated 
further than Mycobacterium species using 16S rDNA sequencing (i.e. likely to be new 
species) were isolated from native forest soils. 
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Chapter 1 Introduction 
Worldwide, the incidence of environmental mycobacterial infections is increasing but 
there are limited data on the diversity of mycobacteria isolated from the environment. 
Often the studies available have focussed on a particular species associated with 
human disease rather than on overall diversity. Without a baseline knowledge of 
species diversity it is difficult to assess changes within the mycobacterial population 
and whether a previously uncommon isolate may now cause disease due to a change 
in habitat. Unlike tuberculosis, infection due to non-tuberculous mycobacteria is not a 
notifiable disease. Therefore, limited data on the number, type and epidemiology of 
non-tuberculous mycobacterial infections in New Zealand are available. It is believed 
that Mycobacterium avium complex (MAC) is the most common cause of non-
tuberculous mycobacterial infections in New Zealand and Australia. It is a well 
known fact that the environment is the primary source of MAC infection (Falkinham 
1996). 
Exposure of MAC isolates to macrolides, antibiotics commonly used to treat MAC 
infections, has been identified as a major factor in the development of antimicrobial 
resistance (Stormer et al. 1989; Yago et al. 1995). Exposure to sub-inhibitory levels 
of these antibiotics found in the environment may also contribute to this resistance 
(Kurnmerer 2004). There are no local data available on the antimicrobial 
susceptibility of MAC isolates from the environment. Without available data it is 
difficult to assess if human impact (i.e., agriculture or urbanisation) has had any effect 
on the susceptibility of wild type MAC to macrolide antibiotics and if drug resistant 
MAC strains exist in the New Zealand environment. 
The aim of this project was to develop improved techniques to isolate environmental 
mycobacteria and to compare the diversity of mycobacterial species from different 
New Zealand soil environments using genotypic methods for identification. The 
susceptibility of MAC isolates to macrolides was also assessed to investigate whether 
specific environments harbour isolates with increased resistance to macrolide 
antibiotics. 
Knowledge of mycobacterial diversity and antimicrobial susceptibility may provide 
insights into the indigenous mycobacterial populations in New Zealand soil 
environments. Data on existing mycobacterial populations, their environmental niche 
and susceptibility to antibiotics can be used to enhance our ability to predict and 
prevent conditions that lead to infections. These data may be used to further 
understand the effect of human impact on the susceptibility and epidemiology of non-
tuberculous mycobacteria. 
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